# Pilot and Feasibility Study for the Treatment of Pre-diabetes in Patients With Cystic Fibrosis

> **NCT00763412** · NA · COMPLETED · sponsor: **Arbelaez, Ana Maria** · enrollment: 31 (actual)

## Conditions studied

- Cystic Fibrosis Related Diabetes
- Pancreatic Insufficiency

## Interventions

- **DRUG:** placebo
- **DRUG:** repaglinide

## Key facts

- **NCT ID:** NCT00763412
- **Lead sponsor:** Arbelaez, Ana Maria
- **Sponsor class:** INDIV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** 2013-01
- **Final completion:** 2013-01
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2017-06-05

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00763412

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00763412, "Pilot and Feasibility Study for the Treatment of Pre-diabetes in Patients With Cystic Fibrosis". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00763412. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*